Title Date Topic Engagement News Relevance
SARS-CoV-2 spike binding peptides: A potential therapeutic approach for COVID-19

Santhamani Ramasamy et al in journal of immunology (5.422)

Source crossref_works_2020_03_25
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 1.0
Development and Characterization of Potential Neutralizaing Antibodies to SARS-CoV-2 from Phage Display Human Antibody Library System

In Ho Park et al in journal of immunology (5.422)

Source crossref_works_2020_03_25
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 0.7
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

Naveen Chandra Suryadevara et al in journal of immunology (5.422)

Source crossref_works_2020_03_25
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 0.2
Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates

Chanbora Chea et al in bioRxiv : the preprint server for biology

Source crossref_works_2020_03_25 Preprint
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 0.2
The SARS-CoV-2 proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms

Christine Vazquez et al in journal of immunology (5.422)

Source crossref_works_2020_03_25
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 0.3
Cross-neutralizing antibody recognition of sarbecoviruses

Hejun Liu et al in journal of immunology (5.422)

Source crossref_works_2020_03_25
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 0.3
Optimizing immunoassay-based selection of donors for COVID-19 convalescent plasma

Hanora A Van Ert et al in journal of immunology (5.422)

Source crossref_works_2020_03_25
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 0.3
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapies

Carolin Schwake et al in multiple sclerosis journal (6.312)

Source crossref_works_2020_03_25
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 0.4
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses

John Altin et al in journal of immunology (5.422)

Source crossref_works_2020_03_25
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 0.4
An interferon-stimulated transcriptionally independent isoform of ACE2 inhibits SARS-CoV-2 infection

Olusegun O Onabajo et al in journal of immunology (5.422)

Source crossref_works_2020_03_25
Feb 07, 2023 Protein (iACE2 & Binding Domain (RBD) 0 0 0.5